Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI)
NCT ID: NCT06429774
Last Updated: 2024-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2024-08-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Value of Multimodal MR Imaging in Cognitive Assessment of Patients With Moderate Traumatic Brain Injury
NCT06099210
The Research for New Clinical Diagnostic Strategy of Specific Biomarkers for Traumatic Brain Injury
NCT03976492
Effect of Multimodal Monitoring Cluster Management on Patients with Severe Traumatic Brain Injury
NCT06583252
Imaging Biomarkers of Mild Traumatic Brain Injury: a Longitudinal Cohort Study
NCT02868684
A Study of Biomarkers of Mild Traumatic BRAIN Injury
NCT04032509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a prospective, multicenter, observational study designed to enroll 2,000 patients under the age of 90 years with traumatic brain injury in the presence of clinical symptoms confirmed by computed tomography or magnetic resonance imaging.The primary outcome is the Extended Glasgow Outcome Score within 12 months. Secondary outcomes include the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9(PHQ-9), Rivermead post-concussion symptoms questionnaire(RPQ), PTSD Checklist-5 Version(PCL-5),Six-Item Screener (SIS) and 12-Item Short-Form Health Survey version 2(SF-12v2).
The objective of this study is anticipated to the Beijing-Tianjin-Hebei region a 20 percent increase in the number of cases treated by optimized clinical practice guidelines and a 10 percent decrement in mortality and disability rates among TBI patients in the region.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TBI Group
TBI patients recruited from neurosurgical departments at 50 medical centers in China have apparent clinical symptoms that are confirmed by computed tomography or magnetic resonance imaging.
The exclusion criteria are those who fulfill one of the following conditions:
1. patients ≥90 years of age;
2. patients who did not accept follow-up visits or were unable to complete follow-up assessments;
3. patients with incomplete information;
4. patients who did not obtain written informed consent;
5. patients with concomitant cancer or other serious illnesses.
Neurological function
Neurological function will be examined using Glasgow Coma Scale (GCS) and Extended Glasgow Outcome Scale (GOSE).The GOSE was created as an advancement from the original GOS. The GOSE score categorizes the prognosis of patients with traumatic brain injury into eight categories.The 8 categories are: Dead, Vegetative State, Lower Severe Disability, Upper Severe Disability, Lower Moderate Disability, Upper Moderate Disability, Lower Good Recovery, and Upper Good Recovery.
Mental State, cognitive function, and life quality assessment
Mental State, cognitive function, and life quality will be examined using the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9(PHQ-9), Rivermead post-concussion symptoms questionnaire(RPQ), PTSD Checklist-5 Version(PCL-5),Six-Item Screener(SIS) and 12-Item Short-Form Health Survey version 2(SF-12v2).
Peripheral blood test
Collect peripheral blood samples from patients.
Hematoma test
Collect hematoma fluid, dura mater, and hematoma outer membrane samples from patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurological function
Neurological function will be examined using Glasgow Coma Scale (GCS) and Extended Glasgow Outcome Scale (GOSE).The GOSE was created as an advancement from the original GOS. The GOSE score categorizes the prognosis of patients with traumatic brain injury into eight categories.The 8 categories are: Dead, Vegetative State, Lower Severe Disability, Upper Severe Disability, Lower Moderate Disability, Upper Moderate Disability, Lower Good Recovery, and Upper Good Recovery.
Mental State, cognitive function, and life quality assessment
Mental State, cognitive function, and life quality will be examined using the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9(PHQ-9), Rivermead post-concussion symptoms questionnaire(RPQ), PTSD Checklist-5 Version(PCL-5),Six-Item Screener(SIS) and 12-Item Short-Form Health Survey version 2(SF-12v2).
Peripheral blood test
Collect peripheral blood samples from patients.
Hematoma test
Collect hematoma fluid, dura mater, and hematoma outer membrane samples from patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Traumatic brain injury verified on cranial computed tomography or magnetic resonance imaging
* Written informed consent from patients or their next of kin according to the patient's cognitive status
Exclusion Criteria
* patients who did not accept follow-up visits or were unable to complete follow-up assessments
* patients with incomplete information
* patients who did not obtain written informed consent
* patients with concomitant cancer or other serious illnesses
1 Year
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tiantan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Weiming Liu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Weiming Liu, M.D.
Role: PRINCIPAL_INVESTIGATOR
Beijing Tiantan Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Fengtai You'anmen Hospital
Beijing, Beijing Municipality, China
Beijing Huairou Hospital
Beijing, Beijing Municipality, China
Beijing Luhe Hospital,Capital Medical University
Beijing, Beijing Municipality, China
Beijing Red Cross Emergency Medical Center
Beijing, Beijing Municipality, China
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Beijing Chaoyang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Beijing Chaoyang Integrative Medicine Rescue And First Aid Hospital
Beijing, Beijing Municipality, China
Beijing Daxing District People's Hospital
Beijing, Beijing Municipality, China
Peking University International Hospital
Beijing, Beijing Municipality, China
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Beijing Changping Hospital
Beijing, Beijing Municipality, China
Beijing Mentougou District Hospital
Beijing, Beijing Municipality, China
Liangxiang Hospital
Beijing, Beijing Municipality, China
The First Hospital of Fangshan District, Bejing
Beijing, Beijing Municipality, China
Dongfang Hospital of Beijing University of Chinese Medicine
Beijing, Beijing Municipality, China
Affiliated Hospital Of Hebei University
Baoding, Hebei, China
The No.2 Hospital of Baoding
Baoding, Hebei, China
Anguo Hospital
Baoding, Hebei, China
Rongcheng People's Hospital
Baoding, Hebei, China
Xiongxian Hospital
Baoding, Hebei, China
Baoding Seventh Hospital
Baoding, Hebei, China
Gaobeidian Hospital
Baoding, Hebei, China
Yixian Hospital
Baoding, Hebei, China
Suning Hospital
Cangzhou, Hebei, China
Pingquan Hospital
Chengde, Hebei, China
Luanping Hospital
Chengde, Hebei, China
Hangang Hospital
Handan, Hebei, China
Weixian Chinese Traditional Medicine Hospital
Handan, Hebei, China
The No.1 Hospital Of Yongnian District Handan City
Handan, Hebei, China
Hebei Petro China Central Hospital
Langfang, Hebei, China
Langfang People's Hospital
Langfang, Hebei, China
Edelburg Hospital
Langfang, Hebei, China
Sanhe Hospital
Langfang, Hebei, China
Yanjiao Fuhe No.1 Hospital
Langfang, Hebei, China
Dachang Hui Autonomous County People's Hospital
Langfang, Hebei, China
Xianghe Hospital
Langfang, Hebei, China
Fourth people's Hospital of Langfang
Langfang, Hebei, China
Dacheng Hospital
Langfang, Hebei, China
First Hospital of Qinhuangdao
Qinhuangdao, Hebei, China
Shanhaiguan People's Hospital
Qinhuangdao, Hebei, China
Qinhuangdao Funing District Hospital of Traditional Chinese Medicine
Qinhuangdao, Hebei, China
Lulong Hospital
Qinhuangdao, Hebei, China
Peking University Third Hospital Qinhuangdao Hospital
Qinhuangdao, Hebei, China
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
The Third Hospital Of Shijiazhuang
Shijiazhuang, Hebei, China
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Jingxing Hospital
Shijiazhuang, Hebei, China
Xinle Chinese Traditional Medicine Hospital
Shijiazhuang, Hebei, China
Tangshan Fengrun People's Hospital
Tangshan, Hebei, China
Tangshan Workers' Hospital
Tangshan, Hebei, China
Xingtai Central Hospital
Xingtai, Hebei, China
Xingtai People's Hospital
Xingtai, Hebei, China
Xingtai Xindu District People's Hospital
Xingtai, Hebei, China
Xingtai Nanhe District People's Hospital
Xingtai, Hebei, China
Pingxiang People's Hospital
Xingtai, Hebei, China
Wei County People's Hospital
Xingtai, Hebei, China
Qinghe Central Hospital
Xingtai, Hebei, China
Xingtai Ninth Hospital
Xingtai, Hebei, China
Tianjin First Central Hospital
Tianjin, Tianjin Municipality, China
Tianjin Hospital
Tianjin, Tianjin Municipality, China
Tianjin Fourth Central Hospital
Tianjin, Tianjin Municipality, China
Tianjin Xiqing Hospital
Tianjin, Tianjin Municipality, China
Wuqing People's Hospital
Tianjin, Tianjin Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gesheng Wang, M.D.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Capizzi A, Woo J, Verduzco-Gutierrez M. Traumatic Brain Injury: An Overview of Epidemiology, Pathophysiology, and Medical Management. Med Clin North Am. 2020 Mar;104(2):213-238. doi: 10.1016/j.mcna.2019.11.001.
Galgano M, Toshkezi G, Qiu X, Russell T, Chin L, Zhao LR. Traumatic Brain Injury: Current Treatment Strategies and Future Endeavors. Cell Transplant. 2017 Jul;26(7):1118-1130. doi: 10.1177/0963689717714102.
Jiang JY, Gao GY, Feng JF, Mao Q, Chen LG, Yang XF, Liu JF, Wang YH, Qiu BH, Huang XJ. Traumatic brain injury in China. Lancet Neurol. 2019 Mar;18(3):286-295. doi: 10.1016/S1474-4422(18)30469-1. Epub 2019 Feb 12.
Stocchetti N, Carbonara M, Citerio G, Ercole A, Skrifvars MB, Smielewski P, Zoerle T, Menon DK. Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol. 2017 Jun;16(6):452-464. doi: 10.1016/S1474-4422(17)30118-7.
Steyerberg EW, Wiegers E, Sewalt C, Buki A, Citerio G, De Keyser V, Ercole A, Kunzmann K, Lanyon L, Lecky F, Lingsma H, Manley G, Nelson D, Peul W, Stocchetti N, von Steinbuchel N, Vande Vyvere T, Verheyden J, Wilson L, Maas AIR, Menon DK; CENTER-TBI Participants and Investigators. Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study. Lancet Neurol. 2019 Oct;18(10):923-934. doi: 10.1016/S1474-4422(19)30232-7.
Silverberg ND, Duhaime AC, Iaccarino MA. Mild Traumatic Brain Injury in 2019-2020. JAMA. 2020 Jan 14;323(2):177-178. doi: 10.1001/jama.2019.18134. No abstract available.
Sun D, Jiang B, Ru X, Sun H, Fu J, Wu S, Wang L, Wang L, Zhang M, Liu B, Wang W; for the NESS-China investigators. Prevalence and Altered Causes of Traumatic Brain Injury in China: A Nationwide Survey in 2013. Neuroepidemiology. 2020;54(2):106-113. doi: 10.1159/000501911. Epub 2019 Dec 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SF 2024-1-2042
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.